Sunshine Biopharma Stock Overlap Studies Triangular Moving Average

SBFM Stock  USD 2.86  0.13  4.76%   
Sunshine Biopharma overlap studies tool provides the execution environment for running the Triangular Moving Average study and other technical functions against Sunshine Biopharma. Sunshine Biopharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triangular Moving Average study function is designed to identify and follow existing trends. Sunshine Biopharma overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was nine with a total number of output elements of fifty-two. The Triangular Moving Average shows Sunshine Biopharma double smoothed mean price over a specified number of previous prices (i.e., averaged twice).

Sunshine Biopharma Technical Analysis Modules

Most technical analysis of Sunshine Biopharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Sunshine from various momentum indicators to cycle indicators. When you analyze Sunshine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Sunshine Biopharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Sunshine Biopharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sunshine Biopharma based on widely used predictive technical indicators. In general, we focus on analyzing Sunshine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sunshine Biopharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Sunshine Biopharma's intrinsic value. In addition to deriving basic predictive indicators for Sunshine Biopharma, we also check how macroeconomic factors affect Sunshine Biopharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number6.0K15.0K3.8K2.0K
Receivables Turnover29.292.279.448.97
Hype
Prediction
LowEstimatedHigh
0.142.737.76
Details
Intrinsic
Valuation
LowRealHigh
0.132.617.64
Details
1 Analysts
Consensus
LowTargetHigh
2.733.003.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sunshine Biopharma. Your research has to be compared to or analyzed against Sunshine Biopharma's peers to derive any actionable benefits. When done correctly, Sunshine Biopharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sunshine Biopharma.

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Equity Search Now

   

Equity Search

Search for actively traded equities including funds and ETFs from over 30 global markets
All  Next Launch Module

Sunshine Biopharma pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sunshine Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will appreciate offsetting losses from the drop in the long position's value.

Sunshine Biopharma Pair Trading

Sunshine Biopharma Pair Trading Analysis

When determining whether Sunshine Biopharma is a strong investment it is important to analyze Sunshine Biopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sunshine Biopharma's future performance. For an informed investment choice regarding Sunshine Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(127.90)
Revenue Per Share
197.42
Quarterly Revenue Growth
0.416
Return On Assets
(0.11)
Return On Equity
(0.18)
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.